Thrombotic microangiopathies after kidney transplantation in modern era: nosology based on chronology

Archive ouverte

von Tokarski, Florent | Fillon, Alexandre | Maisons, Valentin | Thoreau, Benjamin | Bayer, Guillaume | Gatault, Philippe | Longuet, Hélène | Sautenet, Benedicte | Büchler, Matthias | Vigneau, Cécile | Fakhouri, Fadi | Halimi, Jean-Michel

Edité par CCSD ; BioMed Central -

International audience. Background: Thrombotic microangiopathies (TMAs) are rare but can be severe in kidney transplant. recipients (KTR). Methods: We analysed the epidemiology of adjudicated TMA in consecutive KTR during the. 2009–2021 period. Results: TMA was found in 77/1644 (4.7%) KTR. Early TMA (n = 24/77 (31.2%); 1.5% of all KTR) occurred during the first two weeks ((median, IQR) 3 [1–8] days). Triggers included acute antibody-mediated rejection (ABMR, n = 4) and bacterial infections (n = 6). Graft survival (GS) was 100% and recurrence rate (RR) was 8%. Unexpected TMA (n = 31/77 (40.2%); 1.5/1000 patient-years) occurred anytime during follow-up (3.0 (0.5–6.2) years). Triggers included infections (EBV/CMV: n = 10; bacterial: n = 6) and chronic active ABMR (n = 5). GS was 81% and RR was 16%. Graft-failure associated TMA (n = 22/77 (28.6%); 2.2% of graft losses) occurred after 8.8 (4.9–15.5) years). Triggers included acute (n = 4) or chronic active (n = 14) ABMR, infections (viral: n = 6; bacterial: n = 5) and cancer (n = 6). 15 patients underwent transplantectomy. RR was 27%. Atypical (n = 6) and typical (n = 2) haemolytic and uremic syndrome, and isolated CNI toxicity (n = 4) were rare. Two-third of biopsies presented TMA features. Conclusions: TMA are mostly due to ABMR and infections; causes of TMA are frequently combined. Management often is heterogenous. Our nosology based on TMA timing identifies situations with distinct incidence, causes and prognosis. © 2023, BioMed Central Ltd., part of Springer Nature.

Suggestions

Du même auteur

What is the impact of blood pressure on neurological symptoms and the risk of ESKD in primary and secondary thrombotic microangiopathies based on clinical presentation: a retrospective study

Archive ouverte | Halimi, Jean-Michel | CCSD

International audience. Background: The impact of blood pressure on neurological symptoms and risk of end-stage kidney disease (ESKD) is unknown in primary and secondary thrombotic microangiopathies (TMAs).Methods: ...

Infection in Patients with Suspected Thrombotic Microangiopathy Based on Clinical Presentation

Archive ouverte | Thoreau, Benjamin | CCSD

International audience. Background and objectives - In contrast to shigatoxin-associated (STEC) causing hemolytic uremic syndrome, STEC-unrelated infections associated with thrombotic microangiopathy are less chara...

Etiology and Outcomes of Thrombotic Microangiopathies

Archive ouverte | Bayer, Guillaume | CCSD

International audience. Background and objectives - Thrombotic microangiopathies constitute a diagnostic and therapeutic challenge. Secondary thrombotic microangiopathies are less characterized than primary thrombot...

Chargement des enrichissements...